Garry Rogers has consolidated his majority ownership of ARG as John McMellan departs.
ARG announced today that Garry Rogers is now its largest shareholder after expanding his investment in the business.
The move continues the consolidation of power for the Rogers family in ARG, with Barry Rogers having already held a 75 per cent stake, with another 20 per cent held by McMellan and five per cent by James Warburton. The finer details of the current shareholding haven't been revealed, although it appears to be total, or near-total, ownership for the Rogers family.
“Moving forward, I plan to be more hands on and hopefully my 60-plus years in this sport and enthusiasm will attract some like-minded people who can work with [chief operating officer] Liam Curkpatrick to re-energise the business.”It is closely tied up with Motorsport Australia on running the SpeedSeries and owns and operates the Bathurst 6 Hour and Bathurst International events.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Polymyxin B therapy based on therapeutic drug monitoring in carbapenem-resistant organisms sepsis: the PMB-CROS randomized clinical trial - Critical CareBackground The appropriate administration regimen of polymyxin B is yet controversial. The present study aimed to explore the optimal dose of polymyxin B under therapeutic drug monitoring (TDM) guidance. Methods In China’s Henan province, 26 hospitals participated in a randomized controlled trial. We included patients with sepsis caused by carbapenem-resistant Gram-negative bacteria (CR-GNB) susceptible to polymyxin B. The patients were randomly divided into a high-dose (HD) group or a low-dose (LD) group and received 150 mg loading dose, 75 mg every 12 h and 100 mg loading dose, 50 mg every 12 h, respectively. TDM was employed to determine if the dose of polymyxin B needs adjustment based on the area under the concentration–time curve across 24 h at a steady state (ssAUC0–24) of 50–100 mg h/L. The primary outcome was the 14-day clinical response, and the secondary outcomes included 28- and 14-day mortality. Results This trial included 311 patients, with 152 assigned to the HD group and 159 assigned to the LD group. Intention-to-treat analysis showed that the 14-day clinical response was non-significant (p = 0.527): 95/152 (62.5%) in the HD group and 95/159 (59.7%) in the LD group. Kaplan–Meier’s 180-day survival curve showed survival advantage in the HD group than in the LD group (p = 0.037). More patients achieved the target ssAUC0–24 in the HD than in the LD group (63.8% vs. 38.9%; p = 0.005) and in the septic shock subgroup compared to all subjects (HD group: 71.4% vs. 63.8%, p = 0.037; LD group: 58.3% vs. 38.9%, p = 0.0005). Also, the target AUC compliance was not correlated with clinical outcomes but with acute kidney injury (AKI) (p = 0.019). Adverse events did not differ between the HD and LD groups. Conclusion A fixed polymyxin B loading dose of 150 mg and a maintenance dose of 75 mg every 12 h was safe for patients with sepsis caused by CR-GNB and improves long-term survival. The increased AUC was associated with increased incidence of AKI, and TDM results
Read more »
36 Of The Most Incredible Forgotten Photographs Of Royals At Ascot Over The YearsThe royals have a long history with the famous horse racing event.
Read more »
Camel racing returns to north ShropshireCamel racing will be returning to a village near Whitchurch next month.
Read more »
Jenson Button plans full-time racing return in 20242009 F1 world champion JensonButton plans to race on a full-time basis next year 🤩 Find out where Jenson says he hopes to be racing 👇
Read more »
Jenson Button plans full-time racing return in 2024🗣 'I want to do a full season next year, time permitting.' JensonButton says he’s ready to make a return to full-time racing next year for the first time since 2019. But which series has he been eyeing up? 👀
Read more »
Data leak at Australian law firm spooks government, businessData leak at major law firm sets Australia's government and elites scrambling
Read more »